Portfolio Holdings

Important Information

We want to make investing with us simple and straightforward for all of our clients.

Please select your investor type from the options below.

Alternatively you can register or log in to an existing account.

Please note that by making your selection here you are agreeing to the Woodford Investment Management Ltd Privacy Statement and to our Terms and Conditions.

Home > Funds > LF Woodford Equity Income Fund > Portfolio Holdings

We recognise that openness and transparency are key in building client understanding and we ensure that our clients get unprecedented levels of clear and relevant information about their investments, including unparalleled access to our Investment team and transparency into our portfolio construction.

To keep our investors informed, we are committed to providing full disclosure of the LF Woodford Equity Income Fund’s holdings on a monthly basis.

Please find the portfolio holdings as at 31 December 2017 below.

The details set out are for information purposes only. Care is taken in ensuring this is accurate as at the stated date. However, this is not guaranteed and the portfolio may change at any time. This does not constitute investment advice or any recommendation with regard to the listed stocks.

Register now to receive Portfolio disclosure alerts by email.

LF Woodford Equity Income Fund As at 31 December 2017
  Name Industry % (weight)
1 Imperial Brands Consumer Goods 6.95
2 AstraZeneca Health Care 6.81
3 Legal & General Financials 4.89
4 Lloyds Financials 3.43
5 Burford Capital Financials 3.39
6 Barratt Developments  Consumer Goods 2.81
7 Purplebricks Financials 2.75
8 Prothena Health Care 2.57
9 Provident Financial Financials 2.43
10 IP Group Financials 2.39
11 Taylor Wimpey  Consumer Goods 2.33
12 NewRiver REIT  Financials 2.24
13 Stobart Industrials 2.21
14 Theravance Biopharma Health Care 2.02
15 Benevolent AI (unquoted) Technology 1.94
16 Next Consumer Services 1.90
17 BCA Marketplace Industrials 1.84
18 BTG Health Care 1.76
19 Babcock International Industrials 1.57
20 Alkermes Health Care 1.55
21 Spire Healthcare Health Care 1.38
22 Countryside Properties Consumer Goods 1.34
23 Eddie Stobart Logistics  Industrials 1.33
24 Oxford Nanopore (unquoted) Health Care 1.33
25 Redde Financials 1.29
26 Raven Russia (Convertible Pref) Financials 1.22
27 Forterra Industrials 1.19
28 Drax Utilities 1.16
29 Homeserve Industrials 1.11
30 Paypoint Industrials 1.11
31 AA Industrials 1.00
32 P2P Global Financials 0.99
33 Allied Minds Financials 0.95
34 Capita Industrials 0.89
35 Hostelworld Consumer Services 0.88
36 Horizon Discovery Health Care 0.86
37 Phoenix Spree Deutschland Financials 0.85
38 CityFibre Telecommunications 0.79
39 Breedon Industrials 0.78
40 Malin Financials 0.77
41 Oakley Capital Financials 0.75
42 Watkin Jones Consumer Goods 0.74
43 Benchmark Health Care 0.70
44 Circassia Health Care 0.69
45 Mereo Biopharma Health Care 0.66
46 Draper Esprit Financials 0.65
47 Thin Film Electronics Industrials 0.63
48 VPC Specialty Lending Financials 0.62
49 Idex Technology 0.61
50 Honeycomb Investment Trust Financials 0.58
51 Xeros Industrials 0.57
52 Atom Bank (unquoted) Financials 0.55
53 Non-Standard Finance Financials 0.54
54 Card Factory Consumer Services 0.53
55 4D Pharma Health Care 0.53
56 Immunocore A (unquoted) Health Care 0.52
57 Viamet (unquoted) Health Care 0.49
58 Arix Bioscience  Financials 0.45
59 Verseon Health Care 0.44
60 Eve Sleep Consumer Goods 0.44
61 Raven Russia Financials 0.43
62 Sabina Estates Pref Financials 0.43
63 Crest Nicholson Consumer Goods 0.41
64 Sirius Real Estate Financials 0.40
65 Gigaclear (unquoted) Telecommunications 0.39
66 Eurocell Industrials 0.39
67 Evofem D (unquoted) Health Care 0.38
68 Crystal Amber Financials 0.37
69 Oxford Sciences Innovation (unquoted) Financials 0.34
70 Time Out Consumer Services 0.32
71 Proton Partners International (unquoted) Health Care 0.31
72 Cequr (unquoted) Health Care 0.27
73 Mercia Technologies Financials 0.26
74 Tissue Regenix Health Care 0.26
75 Ombu Pref (unquoted) Financials 0.25
76 A J Bell (unquoted) Financials 0.23
77 Strix Industrials 0.22
78 Mafic (unquoted) Industrials 0.21
79 Spin Transfer Technologies (unquoted) Technology 0.20
80 Cell Medica (unquoted) Health Care 0.18
81 Nexeon (unquoted) Industrials 0.18
82 Abzena Health Care 0.16
83 Accelerated Digital Ventures A (unquoted) Financials 0.15
84 AMO Pharma (unquoted) Health Care 0.15
85 RM2 International 9% convertible Industrials 0.14
86 ReNeuron Health Care 0.14
87 Ratesetter (unquoted) Financials 0.14
88 Kymab B Pref (unquoted) Health Care 0.13
89 Autolus (unquoted) Health Care 0.12
90 Netscientific Health Care 0.12
91 Drayson Technologies C (unquoted) Technology 0.11
92 Vernalis Health Care 0.11
93 Origin (unquoted) Health Care 0.11
94 Industrial Heat A1 Pref (unquoted) Industrials 0.10
95 Hvivo Health Care 0.10
96 Cambridge Innovation Capital (unquoted) Financials 0.09
97 Utilitywise Industrials 0.09
98 Silence Therapeutics Health Care 0.08
99 Viamet (unquoted) Health Care 0.06
100 Industrial Heat A2 Pref (unquoted) Industrials 0.06
101 Immunocore (unquoted) Health Care 0.05
102 Sabina Estates (unquoted) Financials 0.05
103 Midatech Pharma Health Care 0.05
104 Mafic B (unquoted) Industrials 0.05
105 Kymab C Pref (unquoted) Health Care 0.04
106 Novabiotics (unquoted) Health Care 0.04
107 Abaco Capital Health Care 0.04
108 e-Therapeutics Health Care 0.04
109 Halosource Reg S Industrials 0.04
110 Carrick Therapeutics (unquoted) Health Care 0.04
111 Northwest Biotherapeutics Health Care 0.04
112 Itaconix Basic Materials 0.03
113 Emba (unquoted) Health Care 0.03
114 Synairgen Health Care 0.02
115 Metalysis (unquoted) Industrials 0.02
116 RM2 International Industrials 0.02
117 Emba - Series 2 (unquoted) Health Care 0.01
118 Brave Bison Technology 0.01
119 Evofem (unquoted) Health Care 0.01
120 Origin (warrants) (unquoted) Health Care 0.01
121 Evofem C (unquoted) Health Care 0.01
122 Origin (convertible pref) (unquoted) Health Care 0.01

What are the risks?

  • The value of the fund and any income from it may go down as well as up, so you may get back less than you invested
  • Past performance cannot be relied upon as a guide to future performance
  • The annual management charge is charged to capital, so the income of the fund may be higher but capital growth may be restricted or capital may be eroded
  • The fund may invest in other transferable securities, money market instruments, warrants, collective investment schemes and deposits
  • The fund may invest in overseas securities and be exposed to currencies other than pound sterling
  • The fund may invest in unquoted securities, which may be less liquid and more difficult to realise than publicly traded securities

Important information

Before investing, you should read the Key Investor Information Document (KIID) for the fund, and the Prospectus which, along with our terms and conditions, can be obtained from the downloads page or from our registered office. If you have a financial adviser, you should seek their advice before investing. Woodford Investment Management Ltd is not authorised to provide investment advice.

Woodford Investment Management Ltd is authorised and regulated by the Financial Conduct Authority (firm reference number 745433). Incorporated in England and Wales, company number 10118169. Registered address 9400 Garsington Road, Oxford OX4 2HN.

Woodford Patient Capital Trust plc is incorporated in England and Wales, company number 09405653. Registered as an investment company under section 833 of the Companies Act 2006. Registered address Beaufort House, 51 New North Road, Exeter, EX4 4EP.

The Woodford Funds (Ireland) ICAV (the “Fund”) has appointed as Swiss Representative Oligo Swiss Fund Services SA, Av. Villamont 17, 1005 Lausanne, Switzerland. The Fund’s Swiss paying agent is Neue Helvetische Bank AG. All fund documentation including, Prospectus, Key Investor Information Documents, Instrument of Incorporation and financial reports may be obtained free of charge from the Swiss Representative in Lausanne. The place of performance and jurisdiction for all shares distributed in or from Switzerland is at the registered office of the Swiss Representative. Fund prices can be found at www.fundinfo.com.

© 2018 Woodford Investment Management Ltd.
All rights reserved.

By using this website you are automatically agreeing to the Woodford Investment Management Ltd privacy statement